Matches in Wikidata for { <http://www.wikidata.org/entity/Q66405063> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66405063 description "clinical trial" @default.
- Q66405063 description "ensayu clínicu" @default.
- Q66405063 description "klinisch onderzoek" @default.
- Q66405063 description "клінічне випробування" @default.
- Q66405063 name "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 name "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 type Item @default.
- Q66405063 label "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 label "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 prefLabel "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 prefLabel "Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders" @default.
- Q66405063 P1050 Q66405063-2B6625AA-650C-4F92-B8E5-4BC97E4CFAF9 @default.
- Q66405063 P1050 Q66405063-2D70085F-18EE-443F-A069-C2F5E5D1E329 @default.
- Q66405063 P1050 Q66405063-409C85A3-D0C0-4EE4-826A-46E41BEA696B @default.
- Q66405063 P1050 Q66405063-96BCE5F7-6ED7-4B3B-8994-09C0F4F2B525 @default.
- Q66405063 P1050 Q66405063-9A985882-A410-49BD-98BF-7FF837B3958A @default.
- Q66405063 P1050 Q66405063-A318CC26-1EA1-4896-82DD-43098816C3EE @default.
- Q66405063 P1050 Q66405063-CC110C6C-2728-4646-BADC-1ACDD2FE6A0C @default.
- Q66405063 P1132 Q66405063-017A3390-9E4E-453C-89FF-5D942454BF65 @default.
- Q66405063 P1476 Q66405063-4D195045-F5B6-4E1A-818C-791B048808BA @default.
- Q66405063 P17 Q66405063-40E198AF-0BD9-4E25-A33B-5C6570A16306 @default.
- Q66405063 P2899 Q66405063-56079E8A-C3FE-47EE-95F9-91BF431312B1 @default.
- Q66405063 P3098 Q66405063-247A2189-77CE-4A94-8F48-7C82C3D4247B @default.
- Q66405063 P31 Q66405063-16DD7F89-26FE-4984-A363-93738D028F11 @default.
- Q66405063 P580 Q66405063-7582DFC3-F875-413F-BE0E-9E6009270C05 @default.
- Q66405063 P582 Q66405063-E9730E90-373E-4328-8134-F10DDBCE7506 @default.
- Q66405063 P6099 Q66405063-35CF6DBE-79CE-4457-9BBC-B224EFA57CC1 @default.
- Q66405063 P8363 Q66405063-7E57A6F3-33F6-4464-9878-268FA0C7206F @default.
- Q66405063 P1050 Q1077603 @default.
- Q66405063 P1050 Q178194 @default.
- Q66405063 P1050 Q220570 @default.
- Q66405063 P1050 Q275466 @default.
- Q66405063 P1050 Q32446 @default.
- Q66405063 P1050 Q32778 @default.
- Q66405063 P1050 Q664174 @default.
- Q66405063 P1132 "+160" @default.
- Q66405063 P1476 "Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders" @default.
- Q66405063 P17 Q16 @default.
- Q66405063 P2899 "+18" @default.
- Q66405063 P3098 "NCT02748798" @default.
- Q66405063 P31 Q30612 @default.
- Q66405063 P580 "2019-05-01T00:00:00Z" @default.
- Q66405063 P582 "2020-09-01T00:00:00Z" @default.
- Q66405063 P6099 Q5452194 @default.
- Q66405063 P8363 Q78089383 @default.